IL155604A0 - Tripeptidyl peptidase inhibitors - Google Patents
Tripeptidyl peptidase inhibitorsInfo
- Publication number
- IL155604A0 IL155604A0 IL15560401A IL15560401A IL155604A0 IL 155604 A0 IL155604 A0 IL 155604A0 IL 15560401 A IL15560401 A IL 15560401A IL 15560401 A IL15560401 A IL 15560401A IL 155604 A0 IL155604 A0 IL 155604A0
- Authority
- IL
- Israel
- Prior art keywords
- tripeptidyl peptidase
- peptidase inhibitors
- inhibitors
- cholecystokinis
- ccks
- Prior art date
Links
- 102000003779 Dipeptidyl-peptidases and tripeptidyl-peptidases Human genes 0.000 title abstract 2
- 108090000194 Dipeptidyl-peptidases and tripeptidyl-peptidases Proteins 0.000 title abstract 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 108090000189 Neuropeptides Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002779 inactivation Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24422300P | 2000-10-30 | 2000-10-30 | |
| PCT/US2001/012388 WO2001080419A2 (en) | 2000-04-18 | 2001-04-17 | System and method for frequency translation using an image reject mixer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL155604A0 true IL155604A0 (en) | 2003-11-23 |
Family
ID=22921880
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15560401A IL155604A0 (en) | 2000-10-30 | 2001-10-24 | Tripeptidyl peptidase inhibitors |
| IL155604A IL155604A (he) | 2000-10-30 | 2003-04-28 | מעכבי טריפפטידיל פפטידאז, תכשירים רוקחיים המכילים אותם ותהליכים להכנתם |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL155604A IL155604A (he) | 2000-10-30 | 2003-04-28 | מעכבי טריפפטידיל פפטידאז, תכשירים רוקחיים המכילים אותם ותהליכים להכנתם |
Country Status (25)
| Country | Link |
|---|---|
| US (4) | US7125891B2 (he) |
| EP (1) | EP1392291B1 (he) |
| JP (1) | JP2004512365A (he) |
| KR (1) | KR100820598B1 (he) |
| CN (2) | CN100400040C (he) |
| AT (1) | ATE363276T1 (he) |
| AU (2) | AU2479702A (he) |
| BG (1) | BG107729A (he) |
| CA (1) | CA2422617C (he) |
| CZ (1) | CZ20031422A3 (he) |
| DE (1) | DE60128731T2 (he) |
| DK (1) | DK1392291T3 (he) |
| EA (1) | EA006443B1 (he) |
| EE (1) | EE200300168A (he) |
| ES (1) | ES2287185T3 (he) |
| HU (1) | HU230376B1 (he) |
| IL (2) | IL155604A0 (he) |
| MX (1) | MXPA03003868A (he) |
| NO (1) | NO324503B1 (he) |
| NZ (1) | NZ525928A (he) |
| PL (1) | PL205536B1 (he) |
| PT (1) | PT1392291E (he) |
| SK (1) | SK6282003A3 (he) |
| WO (1) | WO2002036116A2 (he) |
| ZA (1) | ZA200303302B (he) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2479702A (en) | 2000-10-30 | 2002-05-15 | Janssen Pharmaceutica Nv | Tripeptidyl peptidase inhibitors |
| US7041681B2 (en) | 2002-04-29 | 2006-05-09 | Janssen Pharmaceutica N.V. | Compounds as opioid receptor modulators |
| AU2012268813B2 (en) * | 2002-04-29 | 2015-04-30 | Janssen Pharmaceutica N.V. | Heterocyclic derivatives as opioid modulators |
| AU2003280985A1 (en) * | 2002-07-10 | 2004-02-02 | Bayer Healthcare Ag | Regulation of human tripeptidyl peptidase ii |
| AU2003264018A1 (en) | 2002-08-09 | 2004-02-25 | Astrazeneca Ab | Compounds having an activity at metabotropic glutamate receptors |
| JP2007503453A (ja) * | 2003-05-14 | 2007-02-22 | ノボ ノルディスク アクティーゼルスカブ | 肥満症を治療するための新規化合物 |
| KR101166342B1 (ko) | 2004-03-15 | 2012-07-18 | 얀센 파마슈티카 엔.브이. | 아편계 약물 수용체 조절자로서의 신규의 화합물 |
| WO2006028970A1 (en) | 2004-09-02 | 2006-03-16 | Cengent Therapeutics, Inc. | Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases |
| ES2535048T3 (es) * | 2005-03-14 | 2015-05-04 | Janssen Pharmaceutica Nv | Proceso para la preparación de moduladores de opioides |
| BRPI0618523A2 (pt) * | 2005-11-11 | 2011-09-06 | Hoffmann La Roche | compostos de aminas cìclicas fundidas carbocìclicas, composições farmacêuticas e usos dos mesmos |
| US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
| US7749995B2 (en) | 2006-05-11 | 2010-07-06 | Janssen Pharmaceutica Nv | 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors |
| CA2651942A1 (en) | 2006-05-11 | 2008-07-03 | Janssen Pharmaceutica N.V. | 1,2,3,4-tetrahydro-quinoline derivatives as cetp inhibitors |
| US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
| GB0709031D0 (en) | 2007-05-10 | 2007-06-20 | Sareum Ltd | Pharmaceutical compounds |
| GB201202027D0 (en) | 2012-02-06 | 2012-03-21 | Sareum Ltd | Pharmaceutical compounds |
| ES2566205T3 (es) | 2012-03-02 | 2016-04-11 | Sareum Limited | Inhibidores de quinasa TYK2 |
| EP2708535A1 (en) | 2012-05-11 | 2014-03-19 | Les Laboratoires Servier | Agents for treating disorders involving modulation of ryanodine receptors |
| WO2014134306A1 (en) * | 2013-03-01 | 2014-09-04 | Zalicus Pharmaceuticals, Ltd. | Heterocyclic inhibitors of the sodium channel |
| US9675587B2 (en) | 2013-03-14 | 2017-06-13 | Allergan Holdings Unlimited Company | Opioid receptor modulator dosage formulations |
| GB201617871D0 (en) | 2016-10-21 | 2016-12-07 | Sareum Limited | Pharmaceutical compounds |
| CN109906221B (zh) * | 2016-11-01 | 2021-10-01 | 日本农药株式会社 | N-烷基磺酰基吲哚啉化合物以及含有该化合物的农业园艺用杀虫剂及其使用方法 |
| GB201816369D0 (en) | 2018-10-08 | 2018-11-28 | Sareum Ltd | Pharmaceutical compounds |
| IL292156B2 (he) * | 2019-10-17 | 2026-05-01 | Givaudan Sa | אזאצילים מותמרים כמאפנני trmp8 |
| GB202005114D0 (en) | 2020-04-07 | 2020-05-20 | Sareum Ltd | Crystalline Forms of a Pharmaceutical Compound |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE584914A (he) | 1958-11-24 | |||
| JPS50439B1 (he) * | 1970-04-27 | 1975-01-09 | ||
| CH543479A (de) | 1970-05-06 | 1973-10-31 | Hoffmann La Roche | Verfahren zur Herstellung von Phenyläthylaminderivaten |
| GB2146026A (en) | 1983-09-07 | 1985-04-11 | Tanabe Seiyaku Co | Peptides and process for preparing the same |
| JPS61227506A (ja) | 1985-04-01 | 1986-10-09 | Nippon Tokushu Noyaku Seizo Kk | カルバモイルイミダゾ−ル類、その中間体、それらの製法並びに除草剤又は農園芸用殺菌剤 |
| US5159081A (en) | 1991-03-29 | 1992-10-27 | Eli Lilly And Company | Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists |
| US5338135A (en) | 1991-04-11 | 1994-08-16 | Sumitomo Electric Industries, Ltd. | Drill and lock screw employed for fastening the same |
| FR2678938B1 (fr) | 1991-07-10 | 1993-10-08 | Rhone Poulenc Rorer Sa | Derives de pyrrolidine, leur preparation et les medicaments les contenant. |
| JPH05339240A (ja) | 1992-06-04 | 1993-12-21 | Yamanouchi Pharmaceut Co Ltd | テトラヒドロイソキノリンアミド誘導体 |
| SE9402880D0 (sv) | 1994-08-30 | 1994-08-30 | Astra Ab | New peptide derivatives |
| FR2733995B1 (fr) | 1995-05-09 | 1997-07-25 | Inst Nat Sante Rech Med | Inhibiteurs de l'inactivation de neuropeptides endogenes notamment la cholecystokinine, leurs procedes de preparation leur utilisation comme medicaments et procede de criblage de medicaments |
| FR2735776B1 (fr) * | 1995-06-22 | 1997-07-18 | Synthelabo | Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique |
| EP0946587A2 (en) * | 1996-12-16 | 1999-10-06 | Fujisawa Pharmaceutical Co., Ltd. | New amide compounds |
| US5965537A (en) * | 1997-03-10 | 1999-10-12 | Basf Aktiengesellschaft | Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus |
| JP3943332B2 (ja) * | 1997-12-23 | 2007-07-11 | アンスティテュ ナシオナル ドゥ ラ サントゥ エ ドゥ ラ ルシェルシェ メディカル（イーエヌエスエーエールエム） | トリペプチジルペプチダーゼインヒビター |
| US6127381A (en) * | 1998-04-28 | 2000-10-03 | Basu; Amaresh | Isoquinoline compound melanocortin receptor ligands and methods of using same |
| HUP0102847A2 (hu) * | 1998-06-03 | 2001-12-28 | Amgen Inc. | N-heterociklusos karbonsavak és izoszter karbonsavak karbamidjai és karbamátjai, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények |
| US6916905B2 (en) | 2000-03-24 | 2005-07-12 | The United States Of America As Represented By The Department Of Health And Human Services | Dmt-Tic di-and tri-peptidic derivatives and related compositions and methods of use |
| AU2479702A (en) | 2000-10-30 | 2002-05-15 | Janssen Pharmaceutica Nv | Tripeptidyl peptidase inhibitors |
| FR2816207B1 (fr) | 2000-11-08 | 2003-01-03 | Oreal | Composition de teinture d'oxydation pour fibres keratiniques comprenant un polyurethane associatif cationique |
| US6755387B2 (en) | 2001-02-08 | 2004-06-29 | Symons Corporation | Transition strip for disparate concrete forms |
-
2001
- 2001-10-24 AU AU2479702A patent/AU2479702A/xx active Pending
- 2001-10-24 CZ CZ20031422A patent/CZ20031422A3/cs unknown
- 2001-10-24 DK DK01992570T patent/DK1392291T3/da active
- 2001-10-24 KR KR1020037004180A patent/KR100820598B1/ko not_active Expired - Lifetime
- 2001-10-24 NZ NZ525928A patent/NZ525928A/en not_active IP Right Cessation
- 2001-10-24 IL IL15560401A patent/IL155604A0/xx unknown
- 2001-10-24 AT AT01992570T patent/ATE363276T1/de active
- 2001-10-24 ES ES01992570T patent/ES2287185T3/es not_active Expired - Lifetime
- 2001-10-24 CN CNB018181015A patent/CN100400040C/zh not_active Expired - Lifetime
- 2001-10-24 EE EEP200300168A patent/EE200300168A/xx unknown
- 2001-10-24 MX MXPA03003868A patent/MXPA03003868A/es active IP Right Grant
- 2001-10-24 SK SK628-2003A patent/SK6282003A3/sk unknown
- 2001-10-24 CN CN2008101078402A patent/CN101307046B/zh not_active Expired - Lifetime
- 2001-10-24 PT PT01992570T patent/PT1392291E/pt unknown
- 2001-10-24 JP JP2002538928A patent/JP2004512365A/ja active Pending
- 2001-10-24 EP EP01992570A patent/EP1392291B1/en not_active Expired - Lifetime
- 2001-10-24 WO PCT/EP2001/012388 patent/WO2002036116A2/en not_active Ceased
- 2001-10-24 HU HU0302770A patent/HU230376B1/hu unknown
- 2001-10-24 US US10/415,623 patent/US7125891B2/en not_active Expired - Lifetime
- 2001-10-24 AU AU2002224797A patent/AU2002224797B2/en not_active Expired
- 2001-10-24 EA EA200300523A patent/EA006443B1/ru not_active IP Right Cessation
- 2001-10-24 CA CA2422617A patent/CA2422617C/en not_active Expired - Lifetime
- 2001-10-24 DE DE60128731T patent/DE60128731T2/de not_active Expired - Lifetime
- 2001-10-24 PL PL361064A patent/PL205536B1/pl unknown
-
2003
- 2003-04-16 BG BG107729A patent/BG107729A/bg unknown
- 2003-04-28 IL IL155604A patent/IL155604A/he unknown
- 2003-04-29 ZA ZA200303302A patent/ZA200303302B/en unknown
- 2003-04-29 NO NO20031930A patent/NO324503B1/no not_active IP Right Cessation
-
2006
- 2006-08-07 US US11/499,937 patent/US20060276509A1/en not_active Abandoned
-
2007
- 2007-10-30 US US11/928,273 patent/US7947713B2/en not_active Expired - Fee Related
-
2011
- 2011-05-19 US US13/111,010 patent/US8247432B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2479702A (en) | Tripeptidyl peptidase inhibitors | |
| MX2009009540A (es) | Inhibidores de metaloproteasa que contienen una porcion heterociclica. | |
| YU65802A (sh) | Derivati azetidina, njihovo dobivanje i farmaceutske smeše koje ih sadrže | |
| MY136789A (en) | Metalloproteinase inhibitors | |
| PL369530A1 (en) | Chemical compounds | |
| TW200615275A (en) | Hepatitis C inhibitor dipeptide analogs | |
| MX9804623A (es) | Precursores inactivos de farmacos inhibidores de trombina. | |
| JO2654B1 (en) | Multiple aryl caroxa amides are useful as lipid - lowering agents | |
| MY122829A (en) | Linezolid-crystal form ii | |
| DOP2001000205A (es) | Derivados de ciclopentil-glutaramida como inhibidores de endopeptidasa neutra | |
| DE60135919D1 (de) | Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivate | |
| ATE232873T1 (de) | Phosphonsaürederivate als ptp-1b-inhibitoren | |
| BG104885A (en) | Novel heterocyclically substituted amides with cysteine protease-inhibiting effect | |
| BR0313969A (pt) | Inibidores de oxitocina | |
| ATE411287T1 (de) | Neue metallproteinaseinhibitoren | |
| DE59900730D1 (de) | Korrosionsinhibitoren enthaltender Injektionszement | |
| MXPA03003942A (es) | Compuestos bis-heterociclicos con actividad antitumoral y quimiosensibilizante. | |
| MY128164A (en) | Compounds | |
| EA199800200A1 (ru) | Ингибиторы пролилэндопептидазы | |
| ATE193526T1 (de) | Alkylierte styrole als prodrugs zu cox-2- inhibitoren | |
| GB0327323D0 (en) | Novel pharmaceuticals | |
| NO20033921L (no) | Inhibitor av monoaminopptak | |
| MXPA03002493A (es) | Proceso eficiente para preparacion de un inhibidor del factor xa. | |
| GB2348423B (en) | Novel anhydrofructose antioxidant | |
| WO2005034838A3 (en) | Protease inhibitors |